Congenital Nasolacrimal Duct Obstruction
5
0
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
7 treatments under study, led by Standardized Lacrimal Sac Massage
Research Leaders
6 sponsors active, led by Kazakh Eye Research Institute
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Efficacy and Safety of Piclosept in the Complex Treatment of Neonatal Dacryocystitis
Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only
Endoscopy Assisted Probing Versus Simple Probing in Primary Congenital Nasolacrimal Duct Obstruction
Safety and Efficacy Study of Besivance™ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children
The Factors That Affected the Outcome of Treatment of Congenital Nasolacrimal Duct Obstruction
Research Network
Common Treatments
- Standardized Lacrimal Sac Massage1
- Levofloxacin1
- Endodiathermy Probe And Intubation Versus Intubation1
- Endoscopy Assisted Probing Procedure1
- Besifloxacin1
Active Sponsors
- Kazakh Eye Research Institute1
- Cathay General Hospital1
- Bausch & Lomb Incorporated1
- Rutgers, The State University of New Jersey1
- Tehran University of Medical Sciences1
Top Investigators
Farabi Hospital, Tehran University of Medical Sciences
Institute of Ophthalmology and Visual Science, RUTGERS-New Jersey Medical School
professor of ophthalmology cairo university
Kazakh Research Institute of Eye Diseases
Department of Ophthalmology, Cathay General Hospital
Related Conditions
- Neonatal Dacryocystitis1